OXiGENE News

News on OXiGENE (Ticker: OXGN) continually updated from thousands of sources around the net.

Thursday May 17 | PR-inside.com

Market Report, "OXiGENE, Inc. (OXGN) - Financial and Strategic SWOT Analysis Review", published

OXiGENE, Inc. is a US-based biopharmaceutical company. It engages in development of therapeutics to treat cancer and eye diseases.

Comment?

Related Topix: Biotech, Healthcare Industry, Health, Lung Cancer

Wed May 16, 2012

Money Morning

Investing in Biotech Stocks: Why the "ASCO Effect" Rally Could Start Tomorrow

Silver will rocket past all previous records in 2012. And we've found the top 4 silver investments to make even bigger gains.

Comment?

Wed May 02, 2012

Digital Producer

OXiGENE Announces First Quarter 2012 Earnings Conference Call and Webcast

OXiGENE, Inc. , a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, will report first quarter 2012 results on Wednesday, May 9, 2012.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Mon Apr 30, 2012

BioSpace

OXiGENE Reports Data Showing Median Survival and One-Year Survival...

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia OXiGENE Reports Data Showing Median Survival and One-Year Survival Improvement in Anaplastic Thyroid Cancer Patients Treated With ZYBRESTAT and Chemotherapy SOUTH SAN ... (more)

Comment?

Fri Apr 27, 2012

Money Morning

Biotech Stock Trading: The "ASCO Effect" Can Double Your Money in Days

Last week, a biotech stock we recommended crushed analyst estimates - just as we predicted.

Comment?